PPIST01621
Protein Information
| Protein_Chain | A/B |
|---|---|
| Protein_Sequence | TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR/IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE |
Peptide Information
| Peptide_Chain | C |
|---|---|
| Peptide_Sequence | DFEEIPEEYLQ |
| Peptide_Length | 11 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 1MUE |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.00 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamides. |
|---|---|
| Release_Year | 2003 |
| PMID | 12657281 |
| DOI | 10.1016/S0960-894X(03)00099-4 |